Stoke Therapeutics, Inc. · NASDAQ:STOK
Redmile Group, LLC reported a 6.70% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Redmile Group, LLC reported a 6.70% stake in Stoke Therapeutics, Inc., 4,164,120 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 4,164,120
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 6.70% | 4,164,120 |
| Jeremy C. Green | 6.70% | 4,164,120 |
| Redmile Biopharma Investments III, L.P. | 5.60% | 3,505,612 |
Source
Related
- Stoke Therapeutics, Inc.
- Redmile Group, LLC
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2025
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026